Abstract
ObjectivesWe aimed to evaluate the global scientific output of gene research of myocardial infarction and explore their hotspots and frontiers from 2001 to 2015, using bibliometric methods.MethodsArticles about the gene research of myocardial infarction between 2001 and 2015 were retrieved from the Web of Science Core Collection (WoSCC). We used the bibliometric method and Citespace V to analyze publication years, journals, countries, institutions, research areas, authors, research hotspots, and trends. We plotted the reference co-citation network, and we used key words to analyze the research hotspots and trends.ResultsWe identified 1,853 publications on gene research of myocardial research from 2001 to 2015, and the annual publication number increased with time. Circulation published the highest number of articles. United States ranked highest in the countries with most publications, and the leading institute was Harvard University. Relevant publications were mainly in the field of Cardiovascular system cardiology. Keywords and references analysis indicated that gene expression, microRNA and young women were the research hotspots, whereas stem cell, chemokine, inflammation and cardiac repair were the frontiers.ConclusionsWe depicted gene research of myocardial infarction overall by bibliometric analysis. Mesenchymal stem cells Therapy, MSCs-derived microRNA and genetic modified MSCs are the latest research frontiers. Related studies may pioneer the future direction of this filed in next few years. Further studies are needed.
Highlights
Myocardial infarction (MI), a life-threatening condition, occurs when lack of blood flow, causing the irreversible death of heart muscle
With the development of genetic technology, gene researches have widely launched in MI
Articles or reviews that meet the following criteria were included: (1) The time span is between 2001 and 2015; (2) articles indexed in Web of Science Core Collection (WoSCC); (3) articles on gene research of MI, including original research and reviews; (4) articles with basic info
Summary
Myocardial infarction (MI), a life-threatening condition, occurs when lack of blood flow, causing the irreversible death of heart muscle. The incidence of MI has significantly increased in the past few decades, and MI remains a leading cause of death worldwide. With the development of genetic technology, gene researches have widely launched in MI. Researchers explore the genetics about MI and apply gene therapy for better treatment efficacy. Many genes have been identified an association with MI, such as PCSK9 and. How to cite this article Zhou et al (2018), A bibliometric analysis in gene research of myocardial infarction from 2001 to 2015.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
